A Study for assessing Pain relief with IV Morphine Titration Pain Protocol in cancer patients with severe pain in Emergency Department
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2018/08/015181
- Lead Sponsor
- Tata Memorial Hospital Mumbai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The study will involve all adult cancer patients presenting to the ED in TMH with a predominant complaint of severe pain.
Exclusion Criteria
The study will not consider those patients with delirious or incoherent behaviour, and those patients with red flag signs as bone fracture/impending fracture, epidural metastases, leptomeningeal metastases, infection, obstructed or perforated viscus (acute abdomen), any disease recurrence.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To analyze the effectiveness of implementing IV Morphine Titration Pain Protocol, in controlling severe pain (score above 7) in cancer patients.Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method To ensure sustained pain relief in patients with severe cancer pain on a long-term basis.Timepoint: 1 year